BLUGLASS LIMITED (ASX:BLG) TRADING HALT

Description
The securities of BluGlass Limited (‘BLG’) will be placed in trading halt at the request of BLG, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 24 March 2022 or when the announcement is released to the market.

Issued by

Corey Lian
Compliance Adviser, Listings Compliance (Sydney)

Re: Request for Trading Halt

In accordance with ASX Listing Rule 17.1, BluGlass Limited (“BluGlass” or “the Company”) requests
that ASX Limited grant a trading halt to the quotation of its securities, pending the release of an
announcement by the Company in relation to a capital raising to fund the acquisition of additional
semiconductor manufacturing equipment and capacity.

BluGlass confirms the following:
1. BluGlass requires the trading halt to be applied until trading commencement on Thursday, 24
March 2022.
2. BluGlass will, during the trading halt time frame, seek to finalise the terms of a capital raising.
3. BluGlass is not aware of any reason why the trading halt should not be granted.

Please do not hesitate to contact me if you require any further information.
This announcement has been approved for release by the Board.

Yours sincerely,

Emmanuel Correia
BluGlass Company Secretary

BluGlass logo
About BluGlass

Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.

Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.

The Company combines its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing process with advanced device design and fabrication to deliver differentiated laser solutions. With end-to-end capabilities spanning epitaxy, device design, fabrication, and testing, BluGlass is well-positioned to support critical next-generation photonics applications and sovereign supply chains.

For more information, please contact:

Stefanie Winwood
+61293342300 |swinwood@bluglass.com
James Lennon, Automic Markets
+61414035704 |james.lennon@automicgroup.com.au
Samuel Samhan, BluGlass CFO
ssamhan@bluglass.com